Nexilico is a biotech company focused on precision microbiome engineering through its innovative, modality-agnostic AI-driven discovery platform. Powered by its proprietary microbiome digital twin technology, Nexilico’s platform enables microbiome precision medicine and drives the development of diverse therapeutic strategies across a range of diseases. As a pioneer in next generation of in silico microbiome technologies, Nexilico is unlocking the full potential of the microbiome to address complex health challenges.
Company Details
- Founded
- 2017
- Address
- Danville, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://nexilico.com/news
- Keywords
- Tucson.
- HQ
- Danville
Nexilico Questions
Nexilico's website is http://nexilico.com/news
Nexilico's LinkedIn profile is https://www.linkedin.com/company/nexilico
Nexilico's industry is
Biotechnology Research
Nexilico's top competitors are
Cardiowise, Inc.,
Nexilico, Inc.,
Captura Biopharma,
Snyder Biomedical,
Applied Research Center Of Arkansas,
Sfc Fluidics,
Zelosdx,
Conquerab Inc.,
Souvie Biodelivery,
Valley Fever Solutions.
Nexilico's categories are Biotechnology Research
Nexilico's founding year is 2017
